Richard Gaynor - Net Worth and Insider Trading
Richard Gaynor Net Worth
The estimated net worth of Richard Gaynor is at least $480,455 dollars as of 2024-05-24. Richard Gaynor is the President of R&D of Neon Therapeutics Inc and owns about 156,500 shares of Neon Therapeutics Inc (NTGN) stock worth over $480,455. Details can be seen in Richard Gaynor's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Richard Gaynor has not made any transactions after 2019-11-27 and currently still holds the listed stock(s).
Transaction Summary of Richard Gaynor
Richard Gaynor Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Richard Gaynor owns 4 companies in total, including Alkermes PLC (ALKS) , Neon Therapeutics Inc (NTGN) , and Infinity Pharmaceuticals Inc (INFIQ) among others .
Click here to see the complete history of Richard Gaynor’s form 4 insider trades.
Insider Ownership Summary of Richard Gaynor
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
ALKS | Alkermes PLC | 2019-09-12 | director |
NTGN | Neon Therapeutics Inc | 2020-05-06 | President of R&D |
INFIQ | Infinity Pharmaceuticals Inc | 2020-03-16 | director |
2021-11-19 | director |
Richard Gaynor Latest Holdings Summary
Richard Gaynor currently owns a total of 1 stock. Richard Gaynor owns 156,500 shares of Neon Therapeutics Inc (NTGN) as of November 27, 2019, with a value of $480,455.
Latest Holdings of Richard Gaynor
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
NTGN | Neon Therapeutics Inc | 2019-11-27 | 156,500 | 3.07 | 480,455 |
Holding Weightings of Richard Gaynor
Richard Gaynor Form 4 Trading Tracker
According to the SEC Form 4 filings, Richard Gaynor has made a total of 1 transactions in Neon Therapeutics Inc (NTGN) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Neon Therapeutics Inc is the sale of 65,322 shares on November 27, 2019, which brought Richard Gaynor around $85,572.
Insider Trading History of Richard Gaynor
- 1
Richard Gaynor Trading Performance
Richard Gaynor Ownership Network
Ownership Network List of Richard Gaynor
Ownership Network Relation of Richard Gaynor
Richard Gaynor Owned Company Details
What does Alkermes PLC do?
Who are the key executives at Alkermes PLC?
Richard Gaynor is the director of Alkermes PLC. Other key executives at Alkermes PLC include SVP & Chief Commercial Officer Christian Todd Nichols , SVP & Corp Dev. & Alkermes & Inc. Michael J Landine , and director & Director and CEO & Alkermes plc Richard F Pops .
Alkermes PLC (ALKS) Insider Trades Summary
Over the past 18 months, Richard Gaynor made no insider transaction in Alkermes PLC (ALKS). Other recent insider transactions involving Alkermes PLC (ALKS) include a net sale of 8,128 shares made by Cato T Laurencin , a net sale of 37,551 shares made by Christian Todd Nichols , and a net sale of 41,250 shares made by Nancy Wysenski .
In summary, during the past 3 months, insiders sold 12,976 shares of Alkermes PLC (ALKS) in total and bought 0 shares, with a net sale of 12,976 shares. During the past 18 months, 89,488 shares of Alkermes PLC (ALKS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 89,488 shares.
Alkermes PLC (ALKS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Alkermes PLC Insider Transactions
Richard Gaynor Mailing Address
Above is the net worth, insider trading, and ownership report for Richard Gaynor. You might contact Richard Gaynor via mailing address: C/o Neon Therapeutics, 40 Erie Street, Suite 110, Cambridge Ma 02139.